‘Revolutionary’ new cancer treatment builds on COVID-19 jab tech
‘Revolutionary’ new cancer treatment builds on COVID-19 jab tech LONDON: Vaccitech, a biotechnology company launched by two leaders of the Oxford University COVID-19 vaccine team, is deploying anti-coronavirus technology to revolutionize conventional cancer treatments.The company, founded by professors Sarah Gilbert and Adrian Hill, is financed by the venture capital wing of tech giant Google.It is […]
Read More